• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在长春花碱结构域与微管蛋白相互作用的天然产物:美登素、根霉素、腐草霉素A、多拉司他汀10和15以及海兔毒素B。

Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B.

作者信息

Hamel E

机构信息

Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

出版信息

Pharmacol Ther. 1992;55(1):31-51. doi: 10.1016/0163-7258(92)90028-x.

DOI:10.1016/0163-7258(92)90028-x
PMID:1287674
Abstract

This paper summarizes published data on the interactions of tubulin with antimitotic compounds that inhibit the binding of vinca alkaloids to the protein. These are all relatively complex natural products isolated from higher plants, fungi and marine invertebrate animals. These agents are maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B and their congeners. Effects on tubulin polymerization, ligand binding interactions and structure-activity relationships are emphasized.

摘要

本文总结了已发表的关于微管蛋白与抗有丝分裂化合物相互作用的数据,这些化合物可抑制长春花生物碱与该蛋白的结合。这些都是从高等植物、真菌和海洋无脊椎动物中分离出的相对复杂的天然产物。这些药物包括美登素、根霉素、腐草霉素A、多拉司他汀10和15以及海兔毒素B及其类似物。文中重点阐述了它们对微管蛋白聚合、配体结合相互作用以及构效关系的影响。

相似文献

1
Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B.在长春花碱结构域与微管蛋白相互作用的天然产物:美登素、根霉素、腐草霉素A、多拉司他汀10和15以及海兔毒素B。
Pharmacol Ther. 1992;55(1):31-51. doi: 10.1016/0163-7258(92)90028-x.
2
Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain.多拉司他汀10,一种源自海洋动物的强效细胞生长抑制肽。通过长春花生物碱结合域介导对微管蛋白聚合的抑制作用。
Biochem Pharmacol. 1990 Jun 15;39(12):1941-9. doi: 10.1016/0006-2952(90)90613-p.
3
Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data.海兔毒素B和高海兔毒素B,这两种海洋天然产物可与微管蛋白的长春花结构域结合。通过分析差异细胞毒性数据发现基于微管蛋白的作用机制。
J Biol Chem. 1991 Aug 25;266(24):15882-9.
4
Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites.多拉司他汀10在可交换核苷酸和长春花生物碱位点附近的肽类抗有丝分裂剂的独特位点与微管蛋白结合。
J Biol Chem. 1990 Oct 5;265(28):17141-9.
5
The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain.海绵抑素是微管蛋白聚合的强效细胞毒性抑制剂,它们结合在长春花结构域的一个独特区域。
Biochemistry. 1995 Aug 1;34(30):9714-21. doi: 10.1021/bi00030a009.
6
Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.海绵抑素1,一种具有高度细胞毒性、源自海绵的海洋天然产物,可抑制有丝分裂、微管组装以及长春碱与微管蛋白的结合。
Mol Pharmacol. 1993 Oct;44(4):757-66.
7
Interaction of ustiloxin A with bovine brain tubulin.乌斯他毒素A与牛脑微管蛋白的相互作用。
Biochem Pharmacol. 1994 Apr 29;47(9):1593-9. doi: 10.1016/0006-2952(94)90537-1.
8
Interaction of rhizoxin with bovine brain tubulin.
Cancer Res. 1990 Jul 15;50(14):4277-80.
9
Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.微管蛋白作为抗癌药物的靶点:与有丝分裂纺锤体相互作用的药物。
Med Res Rev. 1998 Jul;18(4):259-96. doi: 10.1002/(sici)1098-1128(199807)18:4<259::aid-med3>3.0.co;2-u.
10
Interaction of marine toxin dolastatin 10 with porcine brain tubulin: competitive inhibition of rhizoxin and phomopsin A binding.海洋毒素多拉司他汀10与猪脑微管蛋白的相互作用:对根赤壳菌素和拟茎点霉毒素A结合的竞争性抑制
Chem Biol Interact. 1994 Dec;93(3):175-83. doi: 10.1016/0009-2797(94)90018-3.

引用本文的文献

1
Identification of therapeutic targets for chronic kidney disease through Mendelian randomization analysis of druggable genes.通过对可成药基因的孟德尔随机化分析确定慢性肾脏病的治疗靶点
Sci Rep. 2025 Mar 28;15(1):10779. doi: 10.1038/s41598-025-94761-0.
2
Design, synthesis and bioactivity evaluation of novel monomethyl auristatin F analogues.新型单甲基澳瑞他汀F类似物的设计、合成及生物活性评价
Mol Divers. 2025 Feb;29(1):535-550. doi: 10.1007/s11030-024-10873-1. Epub 2024 May 18.
3
Computational-Based Discovery of the Anti-Cancer Activities of Pyrrole-Based Compounds Targeting the Colchicine-Binding Site of Tubulin.
基于计算的针对微管蛋白秋水仙素结合部位的吡咯类化合物抗癌活性的发现。
Molecules. 2022 Apr 30;27(9):2873. doi: 10.3390/molecules27092873.
4
Distinct Mechanisms of Cytotoxicity in Novel Nitrogenous Heterocycles: Future Directions for a New Anti-Cancer Agent.新型含氮杂环化合物的细胞毒性作用机制:新型抗癌药物的未来发展方向。
Molecules. 2022 Apr 8;27(8):2409. doi: 10.3390/molecules27082409.
5
Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles.疾病中的微管靶向药物:经典药物,新角色。
Cancers (Basel). 2021 Nov 12;13(22):5650. doi: 10.3390/cancers13225650.
6
Evolutionarily recent dual obligatory symbiosis among adelgids indicates a transition between fungus- and insect-associated lifestyles.叶蝉之间新近发生的共生进化关系暗示了其在真菌相关和昆虫相关生活方式之间的转变。
ISME J. 2022 Jan;16(1):247-256. doi: 10.1038/s41396-021-01056-z. Epub 2021 Jul 22.
7
Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents.三唑类作为生物电子等排体和连接子在微管靶向剂研发中的应用。
RSC Med Chem. 2020 Jan 29;11(3):327-348. doi: 10.1039/c9md00458k. eCollection 2020 Mar 1.
8
Mertansine Inhibits mRNA Expression and Enzyme Activities of Cytochrome P450s and Uridine 5'-Diphospho-Glucuronosyltransferases in Human Hepatocytes and Liver Microsomes.美登素抑制人肝细胞和肝微粒体中细胞色素P450和尿苷5'-二磷酸葡萄糖醛酸转移酶的mRNA表达及酶活性。
Pharmaceutics. 2020 Mar 2;12(3):220. doi: 10.3390/pharmaceutics12030220.
9
A landmark in drug discovery based on complex natural product synthesis.基于复杂天然产物合成的药物发现的里程碑。
Sci Rep. 2019 Jun 17;9(1):8656. doi: 10.1038/s41598-019-45001-9.
10
Current status and contemporary approaches to the discovery of antitumor agents from higher plants.从高等植物中发现抗肿瘤药物的现状和当代方法。
Biotechnol Adv. 2020 Jan-Feb;38:107337. doi: 10.1016/j.biotechadv.2019.01.004. Epub 2019 Jan 8.